로고
About us
Company overview
History
Leadership
Business Strategy
Contact us
Platform Technology
IMBolution Technology
ePENDY Technology
Pipeline
IMB-101
IMB-102
IMB-201
IMB-202
IMB-401/IMB-402
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
언어선택
ENG
KOR
ENG
전체메뉴
About us
Company overview
History
Leadership
Business Strategy
Contact us
Platform Technology
IMBolution Technology
ePENDY Technology
Pipeline
IMB-101
IMB-102
IMB-201
IMB-202
IMB-401/IMB-402
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
Gallery
Innovative Medicines based on
ImmunoModulatory Biologics
Media Room
About us
Platform Technology
Pipeline
Media Room
Careers
Gallery
Notice
News
Gallery
IMBiologics, License Agreement with Navigator Medicines
Date
2024-06-27 10:37:48
View
253
첨부파일
[크기변환]License Agreement.jpg
Prev
IMBiologics, MOU with Canton Biologics
Next
IMBiologics &, Navigator Medicines
목록
President(CEO) : Gyongsik Ha
260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea